Home » Stocks » APEN

Apollo Endosurgery, Inc. (APEN)

Stock Price: $7.80 USD -0.03 (-0.38%)
Updated Jun 11, 2021 4:00 PM EDT - Market closed
Market Cap 210.88M
Revenue (ttm) 45.19M
Net Income (ttm) -16.96M
Shares Out 26.31M
EPS (ttm) -0.71
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 11
Last Price $7.80
Previous Close $7.83
Change ($) -0.03
Change (%) -0.38%
Day's Open 7.84
Day's Range 7.66 - 7.90
Day's Volume 124,624
52-Week Range 1.25 - 7.96

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

AUSTIN, TX / ACCESSWWIRE / June 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures today announce...

1 week ago - Accesswire

AUSTIN, TX / ACCESSWIRE / May 24, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced...

2 weeks ago - Accesswire

AUSTIN, TX / ACCESSWIRE / May 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures today announced...

1 month ago - Accesswire

Apollo Endosurgery, Inc. (APEN) delivered earnings and revenue surprises of 10.53% and 17.63%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m.

1 month ago - Accesswire

Kirk Ellis to Serve as Vice President of US Sales Steve Bosrock to Serve as Vice President of Marketing & Medical Education AUSTIN, TX / ACCESSWIRE / May 3, 2021 / Apollo Endosurgery, Inc. ("Apollo") (N...

1 month ago - Accesswire

AUSTIN, TX / ACCESSWIRE / April 28, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric pro...

1 month ago - Accesswire

Apollo Endosurgery, Inc. (APEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Authors conclude, " Compared to TTS clip, X-Tack is superior for effecting large mucosal defect closure, including durable sealing of full-thickness perforation. " AUSTIN, TX / ACCESSWIRE / April 21, 20...

1 month ago - Accesswire

AUSTIN, TX / ACCESSWIRE / March 19, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announc...

2 months ago - Accesswire

AUSTIN, TX / ACCESSWIRE / March 8, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announce...

3 months ago - Accesswire

AUSTIN, TX / ACCESSWIRE / March 3, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announc...

3 months ago - Accesswire

AUSTIN, TX / ACCESSWIRE / March 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announce...

3 months ago - Accesswire

Apollo Endosurgery (NASDAQ:APEN) announces its next round of earnings this Thursday, February 25. Here is Benzinga's everything-that-matters guide for this Thursday's Q4 earnings announcement.

3 months ago - Benzinga

AUSTIN, TX / ACCESSWIRE / January 5, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures today announ...

5 months ago - Accesswire

NEW YORK, Sept. 1, 2020 /PRNewswire/ -- URGENT: SHAREHOLDER VOTE OCTOBER 7, 2020 WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors o...

9 months ago - PRNewsWire

Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Top Ranked Momentum Stocks to Buy for April 14th

Other stocks mentioned: AQST, FATE, MRSN
1 year ago - Zacks Investment Research

The annual U.S. inflation for the month of November beat expectations and put these ETFs and stocks in focus.

Other stocks mentioned: IHF, IHI, IYR, IYT, XLP, BYND, RPT ...
1 year ago - Zacks Investment Research

Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q1 2019 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

Apollo Endosurgery (APEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 years ago - Zacks Investment Research

Apollo Endosurgery, Inc. (APEN) CEO Todd Newton on Q4 2018 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

About APEN

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content em... [Read more...]

Industry
Medical Devices
Founded
2005
CEO
Gary Atkinson
Employees
158
Stock Exchange
NASDAQ
Ticker Symbol
APEN
Full Company Profile

Financial Performance

In 2020, APEN's revenue was $42.05 million, a decrease of -17.09% compared to the previous year's $50.71 million. Losses were -$22.61 million, -17.57% less than in 2019.

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for APEN stock is "Buy." The 12-month stock price forecast is 11.67, which is an increase of 49.62% from the latest price.

Price Target
$11.67
(49.62% upside)
Analyst Consensus: Buy